The development of a highly sensitive and quantitative SARS-CoV-2 rapid antigen test applying newly developed monoclonal antibodies to an automated chemiluminescent flow-through membrane immunoassay device

Peer Review reports

Original Submission
11 May 2023	Submitted	Original manuscript
Resubmission - Version 2
	Submitted	Manuscript version 2
26 Jun 2023	Author responded	Author comments - Nobuyuki Kurosawa
Resubmission - Version 3
26 Jun 2023	Submitted	Manuscript version 3
30 Jul 2023	Reviewed	Reviewer Report - Zhanding Cui
8 Aug 2023	Reviewed	Reviewer Report
21 Aug 2023	Author responded	Author comments - Nobuyuki Kurosawa
Resubmission - Version 4
21 Aug 2023	Submitted	Manuscript version 4
30 Aug 2023	Reviewed	Reviewer Report
2 Sep 2023	Reviewed	Reviewer Report - Zhanding Cui
Resubmission - Version 5
	Submitted	Manuscript version 5
Publishing
5 Sep 2023	Editorially accepted
26 Sep 2023	Article published	10.1186/s12865-023-00567-y

Back to article page